196 related articles for article (PubMed ID: 26680106)
21. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
[TBL] [Abstract][Full Text] [Related]
22. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
[TBL] [Abstract][Full Text] [Related]
23. Current practice and awareness of pediatric off-label drug use in Shanghai, China -a questionnaire-based study.
Mei M; Xu H; Wang L; Huang G; Gui Y; Zhang X
BMC Pediatr; 2019 Aug; 19(1):281. PubMed ID: 31409339
[TBL] [Abstract][Full Text] [Related]
24. Off-label use of medicines in paediatric inpatients at an Australian teaching hospital.
Ballard CD; Peterson GM; Thompson AJ; Beggs SA
J Paediatr Child Health; 2013 Jan; 49(1):38-42. PubMed ID: 23279160
[TBL] [Abstract][Full Text] [Related]
25. Off-label and unlicensed paediatric prescribing in a community setting: a prospective longitudinal cohort study in Malta.
Ellul IC; Grech V
Paediatr Int Child Health; 2014 Feb; 34(1):12-8. PubMed ID: 24502853
[TBL] [Abstract][Full Text] [Related]
26. Off-label prescribing to children in the United States outpatient setting.
Bazzano AT; Mangione-Smith R; Schonlau M; Suttorp MJ; Brook RH
Acad Pediatr; 2009; 9(2):81-8. PubMed ID: 19329098
[TBL] [Abstract][Full Text] [Related]
27. Off-label paediatric drug use in an Indonesian community setting.
Abdulah R; Khairinisa MA; Pratiwi AA; Barliana MI; Pradipta IS; Halimah E; Diantini A; Lestari K
J Clin Pharm Ther; 2015 Aug; 40(4):409-12. PubMed ID: 25884353
[TBL] [Abstract][Full Text] [Related]
28. Off-label prescribing in pediatric outpatients.
Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
[TBL] [Abstract][Full Text] [Related]
29. Off-label prescribing in a French hospital.
Cras A; Conscience MA; Rajzbaum G; Lillo-Le Louët A; Lopez N; Tersen I; Bezie Y
Pharm World Sci; 2007 Apr; 29(2):97-100. PubMed ID: 17160629
[TBL] [Abstract][Full Text] [Related]
30. The awareness among paediatricians of off-label prescribing in children: a survey of Italian hospitals.
Marchetti F; Bua J; Ventura A; Notarangelo LD; Di Maio S; Migliore G; Bonati M
Eur J Clin Pharmacol; 2007 Jan; 63(1):81-5. PubMed ID: 17124577
[TBL] [Abstract][Full Text] [Related]
31. [Involvement of pharmacists in systems for supervising off-label medications: example of the CAMTEA system for the prescription of baclofen in alcohol use disorder in Northern France].
Auffret M; Rolland B; Deheul S; Lecomte L; Cottencin O; Bordet R; Gautier S;
Ann Pharm Fr; 2014 Jan; 72(1):28-32. PubMed ID: 24438666
[TBL] [Abstract][Full Text] [Related]
32. [Off-label prescriptions in an adult surgical intensive care unit].
Albaladejo P; Caillet B; Moine P; Vigué B; Decorps-Declère A; Benhamou D
Presse Med; 2001 Oct; 30(30):1484-8. PubMed ID: 11712205
[TBL] [Abstract][Full Text] [Related]
33. Off-label use of psychotropic drugs in a Swiss paediatric service: similar results from two different cohort studies.
Feka A; Di Paolo ER; Pauchard JY; Mariguesa A; Gehri M; Sadeghipour F
Swiss Med Wkly; 2022 Jan; 152():w30124. PubMed ID: 35147399
[TBL] [Abstract][Full Text] [Related]
34. Off-label prescribing for children with chronic diseases in Nigeria; findings and implications.
Oshikoya KA; Oreagba IA; Godman B; Fadare J; Orubu S; Massele A; Senbanjo IO
Expert Opin Drug Saf; 2017 Sep; 16(9):981-988. PubMed ID: 28627939
[TBL] [Abstract][Full Text] [Related]
35. Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?
Le Jeunne C; Billon N; Dandon A; ; Berdaï D; Adgibi Y; Bergmann JF; Bordet R; Carpentier A; Cohn E; Courcier S; Girault D; Goni S; Jolliet P; Liard F; Prot-Labarthe S; Simon T; Vernotte C; Westerloppe J
Therapie; 2013; 68(4):225-39. PubMed ID: 23981260
[TBL] [Abstract][Full Text] [Related]
36. Off-label psychotropic prescribing for young persons in medium security.
Haw C; Stubbs J
J Psychopharmacol; 2010 Oct; 24(10):1491-8. PubMed ID: 19423609
[TBL] [Abstract][Full Text] [Related]
37. Perceptions and attitudes towards off-label dispensing for pediatric patients, a study of hospital based pharmacists in Jordan.
Mukattash TL; Alzoubi KH; Abuirjie AM; Jarab AS; Abu Farha RK; Nusair MB; McElnay JC
Saudi Pharm J; 2018 Jan; 26(1):20-24. PubMed ID: 29379329
[TBL] [Abstract][Full Text] [Related]
38. Two decades of off-label prescribing in children: a literature review.
Balan S; Hassali MAA; Mak VSL
World J Pediatr; 2018 Dec; 14(6):528-540. PubMed ID: 30218415
[TBL] [Abstract][Full Text] [Related]
39. Italian paediatricians and off-label prescriptions: loyal to regulatory or guideline standards?
Pandolfini C; Campi R; Clavenna A; Cazzato T; Bonati M
Acta Paediatr; 2005 Jun; 94(6):753-7. PubMed ID: 16188780
[TBL] [Abstract][Full Text] [Related]
40. [Controversies with the "off label" use of medications in the paediatrics--research on the selected paediatricians].
Kuchar E; Szenborn L; Rorat M; Jurek T
Przegl Lek; 2010; 67(1):28-30. PubMed ID: 20509568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
